[ETH_start]

You're so focused on reducing risk from the treatments/procedures themselves that you're not looking at the risks caused by the diseases that the treatments/procedures are not able to cure because they have not innovated fast enough.

This is the classic pro-centralization bias.

Cancer and heart treatment are still in the stone age, with whole-body toxification in chemotherapy, and cutting open people's chest for open heart surgery, still being mainstay treatments.

Costs are also not declining, making cutting edge treatments unaffordable and inaccessible.

Compare to less regulated sectors, where quality has improved orders of magnitude while costs have massively declined, and it's clear that medicine/pharmaceuticals are underpeforming.